Wnt/β-catenin signaling perturbation was achieved with E7449 treatment in Wnt-active colon cancer cells and the profiles generated both by western blot and in gene expression studies appeared very similar to that of the selective tankyrase inhibitor XAV939. This evidence concerns the gene TNKS and malignant colon neoplasm.